Andrew is an engineer and an academic, with a strong background in research commercialisation. During his undergraduate degree he double majored in Chemical and Biological Engineering at the University of Queensland. After graduating with First Class Honours, he then received an Australian Postgraduate Award and went on to complete a PhD in Tissue Engineering at the Australian Institute for Bioengineering and Nanotechnology. Whilst in the final stages of his PhD, Andrew received a Commercialisation Training Scheme Grant that enabled him to complete a Graduate Certificate in Research Commercialisation. This provided the opportunity to work as a commercialisation analyst intern for one of Australia’s largest technology transfer companies, UniQuest, while also equipping him with a broad understanding of various elements of technology innovation. Upon completing his PhD, Andrew was offered a postdoctoral role in the Tissue Engineering Research Group in the Royal College of Surgeons in Ireland (RCSI), which is one of the largest regenerative medicine research groups in Ireland and has a strong focus on translational research. As a research fellow within RCSI, Andrew was primarily responsible for driving the technical and commercial development of a thin-film, collagen-based material for corneal regeneration. Under the supervision of Prof. Fergal O’Brien, Andrew ensured the progression of the technology from early conceptual stages, through to the development of a prototype material that has undergone preclinical in vivo testing and is continuing to progress on the path towards commercialisation and clinical implementation. In his spare time, Andrew likes knitting and cooking on the barbeque.